Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002431 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients
A NA study, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
NCT00002431 is a NA study that has completed, run by Procter and Gamble.
The verdict
NCT00002431, a NA study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate the safety and effectiveness of Peridex (an oral rinse containing chlorhexidine gluconate) for preventing the occurrence of clinically-evident microbiologically-documented oral candidiasis in HIV-positive patients, who are at risk of the disease based on previous history of candidiasis.
Interventions
- DRUG Chlorhexidine gluconate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002431
The ClinicalTrials.gov registry entry for NCT00002431 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chlorhexidine gluconate is the first listed.
NCT00002431 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002431 about?
NCT00002431 is a clinical study titled "The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients". To evaluate the safety and effectiveness of Peridex (an oral rinse containing chlorhexidine gluconate) for preventing the occurrence of clinically-evident microbiologically-documented oral candidiasis in HIV-positive patients, who are at risk of the disease based on previous history of candidiasis.
What is the current status of trial NCT00002431?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002431?
The interventions under investigation include: Chlorhexidine gluconate (DRUG).
Who is sponsoring clinical trial NCT00002431?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.